EVIDENCE PROFILE / PUBLISHED
5-Amino-1MQ
5-Amino-1MQ is a small-molecule nicotinamide N-methyltransferase inhibitor, not a peptide; 1MQ is part of its name. No controlled human administration evidence was identified in the source set reviewed for this profile.
Evidence at a glance
- Human
- Not rated
- Animal/cell
- Not rated
- Approved medicine
- None foundScope: the sources reviewed.
Summarises how much research the profile's sources report, and of what kind. It is not a verdict on the compound or on any catalogue material.
PREPPY BOY ASKS
“A familiar name can hide a different molecule, fragment, formulation, or evidence story.”
The catalogue name is a starting point, not proof of formulation or identity. It is used to probe NNMT, NAD-related metabolism, methyl-donor balance, adipocyte biology, and metabolic-disease models.
Identity
5-Amino-1MQ is a small-molecule nicotinamide N-methyltransferase inhibitor, not a peptide; 1MQ is part of its name.
Biological mechanism or research interest
It is used to probe NNMT, NAD-related metabolism, methyl-donor balance, adipocyte biology, and metabolic-disease models.
Verified approved human uses
No approved human use for 5-Amino-1MQ was verified in the reviewed sources.
Investigational human evidence
No controlled human administration evidence was identified in the source set reviewed for this profile.
Popular claims versus demonstrated findings
Fat-loss, insulin-sensitivity, and liver-health claims come from laboratory or animal models, not demonstrated human benefit.
Human versus animal or cell evidence
Published studies report biochemical, adipocyte, and diet-induced-obesity mouse findings.
Limitations and known risks
Human exposure, salt identity, pharmacokinetics, off-target activity, interactions, and short- or long-term safety remain unknown.
